Biogen reported $469.5M in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US USD 5.02B 880M
Acadia Pharmaceuticals ACAD:US USD 2.14M 531K
Acorda Therapeutics ACOR:US USD 11M 2.2M
ALKERMES ALKS:US USD 50.62M 7.74M
Amgen AMGN:US USD 1.59B 78M
Bayer BAYN:GR EUR 4.25B 1.43B
Biogen BIIB:US USD 469.5M 14.5M
Biomarin Pharmaceutical BMRN:US USD 116.29M 6.84M
Bristol Myers Squibb BMY:US USD 2.35B 324M
Eli Lilly And LLY:US USD 1.58B 148.6M
Esperion Therapeutics ESPR:US USD 6.51M 2.67M
Gilead Sciences GILD:US USD 1.4B 47M
Intercept Pharmaceuticals ICPT:US USD 424K 115K
Intra Cellular Therapies ITCI:US USD 5.85M 1.2M
Merk MRK:US USD 3.43B 715M
Moderna Inc MRNA:US USD 1.1B 281M
Neurocrine Biosciences NBIX:US USD 6.1M 1.3M
Novartis NOVN:VX USD 3.66B 92M
Pfizer PFE:US USD 6.09B 2.58B
Ptc Therapeutics PTCT:US USD 14.01M 4.37M
Puma Biotechnology PBYI:US USD 12.5M 2.42M
Regeneron Pharmaceuticals REGN:US USD 317.8M 20.7M
Sarepta Therapeutics SRPT:US USD 39.95M 2.16M
Seattle Genetics SGEN:US USD 108.12M 2.02M
Teva Pharmaceutical TEVA:IT USD 1.88B 73M
Ultragenyx Pharmaceutical RARE:US USD 8.63M 361K
United Therapeutics UTHR:US USD 37.2M 7.5M
Vertex Pharmaceuticals VRTX:US USD 289.4M 27.6M
YTE INCY:US USD 49.28M 4.05M